Orally administered combined regimens for treatment of Mycobacterium ulcerans infection in mice.

@article{Ji2007OrallyAC,
  title={Orally administered combined regimens for treatment of Mycobacterium ulcerans infection in mice.},
  author={Baohong Ji and Aur{\'e}lie Chauffour and J{\'e}r{\^o}me Robert and S{\'e}bastien Lefrançois and Vincent Jarlier},
  journal={Antimicrobial agents and chemotherapy},
  year={2007},
  volume={51 10},
  pages={3737-9}
}
Eight weeks of treatment with rifampin-streptomycin sterilizes Mycobacterium ulcerans infection in mice. Because the bactericidal activity against M. ulcerans of the combination rifampin-moxifloxacin, rifampin-clarithromycin, or moxifloxacin-clarithromycin was similar to that of rifampin-streptomycin, these combinations might be considered as alternative, orally administered combined regimens for treatment of Buruli ulcer in humans. 

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 24 extracted citations

Similar Papers

Loading similar papers…